title: Estimation of the effect of coumermycin A1 on Salmonella typhimurium promoters by using random operon fusions.
abstract: We have estimated the extent to which relaxation of supercoiling by the DNA gyrase inhibitor coumermycin A1 affects gene expression in vivo in Salmonella typhimurium. We isolated a set of Mu d1-8 Lac+ operon fusions to random promoters and measured the effect of coumermycin A1 on the expression of 67 fusions. The differential rate of synthesis was increased for 70% of the fusions and decreased for 16%, and 13% of the fusions had less than a 25% change in expression. The coumermycin A1 response was found to correlate well (P = 0.067) with the basal level of expression such that coumermycin A1 tended to stimulate fusions with low expression and inhibit those with high expression. Since the vast majority of the fusions were sensitive to coumermycin A1 addition and, therefore, to the level of supercoiling, these results indicate that if the level of supercoiling were to vary under physiological conditions, then major readjustments in the cellular economy would occur.
authors.affiliation: Department of Microbiology, University of Alabama, Birmingham 35294.
authors.forename: S B
authors.initials: SB
authors.lastname: Jovanovich
authors.forename: J
authors.initials: J
authors.lastname: Lebowitz
mesh_terms: D049933:Aminocoumarins; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003374:Coumarins / Q000494:pharmacology; D004269:DNA, Bacterial / Q000187:drug effects; D004274:DNA, Recombinant; D004278:DNA, Superhelical / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D005798:Genes, Bacterial / Q000187:drug effects; D007763:Lac Operon / Q000187:drug effects*; D011401:Promoter Regions, Genetic / Q000187:drug effects*; D012486:Salmonella typhimurium / Q000187:drug effects / Q000235:genetics*; D059005:Topoisomerase II Inhibitors; D014158:Transcription, Genetic; D014161:Transduction, Genetic; D001616:beta-Galactosidase / Q000096:biosynthesis
chemical_list: D049933:Aminocoumarins; D000900:Anti-Bacterial Agents; D003374:Coumarins; D004269:DNA, Bacterial; D004274:DNA, Recombinant; D004278:DNA, Superhelical; D059005:Topoisomerase II Inhibitors; D001616:beta-Galactosidase; C004628:coumermycin